Displaying 1951 - 2000 of 2540 results
Released Company Title Industry Topic
09 Apr 2024
18:29 CEST
VOLTALIA Voltalia consensus as of April 9th, 2024 65101010 Alternative Electricity Other subject
09 Apr 2024
18:23 CEST
KAUFMAN ET BROAD Kaufman & Broad SA: 1ST QUARTER 2024 RESULTS 40202010 Home Construction Income
09 Apr 2024
18:23 CEST
KAUFMAN ET BROAD Kaufman & Broad SA: RESULTATS DU 1ER TRIMESTRE 2024 40202010 Home Construction Income
09 Apr 2024
18:18 CEST
EUROAPI SA EUROAPI streamlines its Executive Committee to improve focus and efficiency 20103015 Pharmaceuticals Other subject
09 Apr 2024
18:18 CEST
EUROAPI SA EUROAPI resserre son Comité exécutif afin de se recentrer et de gagner en efficacité 20103015 Pharmaceuticals Other subject
09 Apr 2024
18:04 CEST
TELEPERFORMANCE Teleperformance SE : Déclaration des transactions sur actions propres réalisées du 2 au 8 avril 2024 (inclus) 50205020 Professional Business Support Services Share history
09 Apr 2024
18:04 CEST
TELEPERFORMANCE Teleperformance SE: Statement on Transactions on Own Shares Carried out from April 2 to April 8, 2024 (inclusive) 50205020 Professional Business Support Services Share history
09 Apr 2024
18:01 CEST
CREDIT AGRICOLE CREDIT AGRICOLE SA :FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE MARS 2024 30101010 Banks Other subject
09 Apr 2024
18:00 CEST
UPERGY UPERGY : facturations du 1er trimestre 2024 : 11,9 M€ 40401010 Diversified Retailers Corporate life
09 Apr 2024
18:00 CEST
HERMES INTERNATIONAL Hermès International: Shares and voting rights as of 31 March 2024 40204020 Clothing and Accessories Share history
09 Apr 2024
18:00 CEST
MAAT PHARMA MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital 20103010 Biotechnology New
09 Apr 2024
18:00 CEST
ORANGE Total number of shares and voting rights at March 31, 2024 15102015 Telecommunications Services Corporate life
09 Apr 2024
18:00 CEST
PHAXIAM THERAPEUTICS Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024 20103010 Biotechnology Other subject
09 Apr 2024
18:00 CEST
IMPLANET IMPLANET annonce son chiffre d’affaires du 1er trimestre 2024 20102010 Medical Equipment Other subject
09 Apr 2024
18:00 CEST
REXEL COMBINED SHAREHOLDERS’ MEETING 50202010 Electrical Components General meeting / Board Meeting
09 Apr 2024
18:00 CEST
MAAT PHARMA MaaT Pharma: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social 20103010 Biotechnology New
09 Apr 2024
18:00 CEST
HERMES INTERNATIONAL Hermès International : Actions et droits de vote au 31 mars 2024 40204020 Clothing and Accessories Share history
09 Apr 2024
18:00 CEST
AFYREN AFYREN: Déclaration des transactions sur actions propres 55201020 Specialty Chemicals Other subject
09 Apr 2024
18:00 CEST
ORANGE Nombre d'actions et de droits de vote au 31 mars 2024 15102015 Telecommunications Services Corporate life
09 Apr 2024
18:00 CEST
PHAXIAM THERAPEUTICS Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 mars 2024 20103010 Biotechnology Other subject
09 Apr 2024
18:00 CEST
REXEL ASSEMBLEE GENERALE MIXTE 50202010 Electrical Components General meeting / Board Meeting
09 Apr 2024
18:00 CEST
IMPLANET IMPLANET Reports its 2024 First-Quarter Revenue 20102010 Medical Equipment Other subject
09 Apr 2024
18:00 CEST
FLEURY MICHON Fleury Michon : Résultats Annuels 2023 45102020 Food Products -
09 Apr 2024
17:47 CEST
FILL UP MEDIA S.A. Fill Up Média : Résultats annuels 2023 : solide dynamique commerciale, signature d’un contrat majeur et structuration des équipes pour le déploiement 40301020 Media Agencies Sales
09 Apr 2024
17:45 CEST
ORPEA INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL DE LA SOCIETE ORPEA 20101010 Health Care Facilities Other subject
09 Apr 2024
17:45 CEST
TRANSGENE Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 20103010 Biotechnology New
09 Apr 2024
17:45 CEST
VINCI Déclaration des transactions sur actions propres du 28 mars au 5 Avril 2024 50101010 Construction Share history
09 Apr 2024
17:45 CEST
COFACE COFACE SA : Assemblée Générale Mixte du jeudi 16 mai 2024 à 14h00 30302025 Property and Casualty Insurance General meeting / Board Meeting
09 Apr 2024
17:45 CEST
IPSOS Communiqué relatif aux rachats d’actions propres (2 avril 2024) 40301020 Media Agencies New
09 Apr 2024
17:45 CEST
VINCI Assemblée générale des actionnaires de VINCI du 9 avril 2024 50101010 Construction General meeting / Board Meeting
09 Apr 2024
17:45 CEST
TECHNIP ENERGIES N.V. Technip Energies annonce la date de publication des résultats financiers du premier trimestre 2024 et de sa conférence téléphonique 60101030 Oil Equipment and Services New
09 Apr 2024
17:45 CEST
ALTEN March 2024 10101010 Computer Services Other subject
09 Apr 2024
17:45 CEST
TRANSGENE Transgene et NEC présentent les premiers signes de bénéfice clinique de leur vaccin individualisé contre le cancer, TG4050, dans les cancers de la tête et du cou à l’AACR 2024 20103010 Biotechnology New
09 Apr 2024
17:45 CEST
VINCI VINCI’s Shareholders’ General Meeting of 9 April 2024 50101010 Construction General meeting / Board Meeting
09 Apr 2024
17:45 CEST
AKWEL AKWEL : nombre d'actions et de droits de vote au 31 mars 2024 40101025 Auto Parts Other subject
09 Apr 2024
17:45 CEST
VINCI Disclosure of trading in own shares from March 28th to April 5th, 2024 50101010 Construction Share history
09 Apr 2024
17:45 CEST
COFACE COFACE SA: Combined Shareholders’ Meeting on Thursday 16 May 2024 at 02.00pm 30302025 Property and Casualty Insurance General meeting / Board Meeting
09 Apr 2024
17:45 CEST
IPSOS Disclosure of trading in own shares under a share buyback programme (2 April 2024) 40301020 Media Agencies New
09 Apr 2024
17:45 CEST
ALTEN Mars 2024 10101010 Computer Services Other subject
09 Apr 2024
17:45 CEST
TECHNIP ENERGIES N.V. Technip Energies Announces Publication Date for First Quarter of 2024 Financial Results and Conference Call 60101030 Oil Equipment and Services New
09 Apr 2024
17:40 CEST
X-FAB SILICON FOUNDRIES SE X-FAB declares its eligibility to the PEA-PME saving plan 10102010 Semiconductors Other subject
09 Apr 2024
17:35 CEST
EURAZEO SE Disclosure of the number of shares and the total number of voting rights as of March 31, 2024 30202010 Asset Managers and Custodians Other subject
09 Apr 2024
17:35 CEST
EURAZEO SE Déclaration du nombre d\'actions composant le capital et du nombre total de droits de vote au 31 mars 2024 30202010 Asset Managers and Custodians Other subject
09 Apr 2024
17:30 CEST
NICOX S.A. Nicox : Assemblée Générale Ordinaire et Extraordinaire 2024 20103015 Pharmaceuticals General meeting / Board Meeting
09 Apr 2024
17:30 CEST
ORAPI ORAPI : Modalités de mise à disposition des documents préparatoires à l'Assemblée Générale mixte du 30 Avril 2024 55201000 Chemicals: Diversified General meeting / Board Meeting
09 Apr 2024
17:30 CEST
NICOX S.A. Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting 20103015 Pharmaceuticals General meeting / Board Meeting
09 Apr 2024
16:57 CEST
DASSAULT SYSTEMES Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of March 31, 2024 10101015 Software Corporate life
09 Apr 2024
16:57 CEST
DASSAULT SYSTEMES Dassault Systèmes : déclaration du nombre d'actions et de droits de vote au 31 mars 2024 10101015 Software Corporate life
09 Apr 2024
16:26 CEST
SECHE ENVIRONNEM. Séché Environnement : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social 65103035 Waste and Disposal Services Other subject
09 Apr 2024
15:38 CEST
PERNOD RICARD Pernod Ricard : déclaration des droits de vote - Mars 2024 45101015 Distillers and Vintners Other subject